Literature DB >> 29251736

PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.

Rania Nasrallah1, Joseph Zimpelmann1, David Eckert1, Jamie Ghossein1, Sean Geddes1, Jean-Claude Beique1, Jean-Francois Thibodeau1, Chris R J Kennedy1,2, Kevin D Burns1,2, Richard L Hébert1.   

Abstract

PGE2 regulates glomerular hemodynamics, renin secretion, and tubular transport. This study examined the contribution of PGE2 EP1 receptors to sodium and water homeostasis. Male EP1-/- mice were bred with hypertensive TTRhRen mice (Htn) to evaluate blood pressure and kidney function at 8 weeks of age in four groups: wildtype (WT), EP1-/-, Htn, HtnEP1-/-. Blood pressure and water balance were unaffected by EP1 deletion. COX1 and mPGE2 synthase were increased and COX2 was decreased in mice lacking EP1, with increases in EP3 and reductions in EP2 and EP4 mRNA throughout the nephron. Microdissected proximal tubule sglt1, NHE3, and AQP1 were increased in HtnEP1-/-, but sglt2 was increased in EP1-/- mice. Thick ascending limb NKCC2 was reduced in the cortex but increased in the medulla. Inner medullary collecting duct (IMCD) AQP1 and ENaC were increased, but AVP V2 receptors and urea transporter-1 were reduced in all mice compared to WT. In WT and Htn mice, PGE2 inhibited AVP-water transport and increased calcium in the IMCD, and inhibited sodium transport in cortical collecting ducts, but not in EP1-/- or HtnEP1-/- mice. Amiloride (ENaC) and hydrochlorothiazide (pendrin inhibitor) equally attenuated the effect of PGE2 on sodium transport. Taken together, the data suggest that EP1 regulates renal aquaporins and sodium transporters, attenuates AVP-water transport and inhibits sodium transport in the mouse collecting duct, which is mediated by both ENaC and pendrin-dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29251736     DOI: 10.1038/labinvest.2017.133

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  44 in total

1.  Urine concentrating defect in prostaglandin EP1-deficient mice.

Authors:  Chris R J Kennedy; Huaqi Xiong; Sherine Rahal; Jacqueline Vanderluit; Ruth S Slack; Yahua Zhang; Youfei Guan; Matthew D Breyer; Richard L Hébert
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-01

2.  Prostaglandin E2 inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells.

Authors:  D M Kaji; H S Chase; J P Eng; J Diaz
Journal:  Am J Physiol       Date:  1996-07

Review 3.  Prostaglandin E2 modulation of blood pressure homeostasis: studies in rodent models.

Authors:  Christina E Swan; Richard M Breyer
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-27       Impact factor: 3.072

Review 4.  Chronic kidney disease: targeting prostaglandin E2 receptors.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

5.  PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.

Authors:  Ramzi Hassouneh; Rania Nasrallah; Joe Zimpelmann; Alex Gutsol; David Eckert; Jamie Ghossein; Kevin D Burns; Richard L Hébert
Journal:  Diabetologia       Date:  2016-03-19       Impact factor: 10.122

6.  Prostaglandin E2 inhibits vasotocin-induced osmotic water permeability in the frog urinary bladder by EP1-receptor-mediated activation of NO/cGMP pathway.

Authors:  Vera Bachteeva; Ekaterina Fock; Elena Lavrova; Svetlana Nikolaeva; Stepan Gambaryan; Rimma Parnova
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-03-15       Impact factor: 3.619

7.  PGE2 inhibits water permeability at a post-cAMP site in rat terminal inner medullary collecting duct.

Authors:  S P Nadler; J A Zimpelmann; R L Hébert
Journal:  Am J Physiol       Date:  1992-02

Review 8.  The role of pendrin in blood pressure regulation.

Authors:  Susan M Wall
Journal:  Am J Physiol Renal Physiol       Date:  2015-11-04

9.  Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy.

Authors:  J H Gurwitz; J Avorn; R L Bohn; R J Glynn; M Monane; H Mogun
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

10.  A novel mouse model of advanced diabetic kidney disease.

Authors:  Jean-Francois Thibodeau; Chet E Holterman; Dylan Burger; Naomi C Read; Timothy L Reudelhuber; Christopher R J Kennedy
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

View more
  9 in total

Review 1.  Diurnal Regulation of Renal Electrolyte Excretion: The Role of Paracrine Factors.

Authors:  Dingguo Zhang; David M Pollock
Journal:  Annu Rev Physiol       Date:  2019-10-21       Impact factor: 19.318

Review 2.  Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure.

Authors:  Lu Wang; Yiqian Wu; Zhanjun Jia; Jing Yu; Songming Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

3.  EP1 receptor antagonism mitigates early and late stage renal fibrosis.

Authors:  Jean-Claude Kresse; Henricus A M Mutsaers; Michael Schou Jensen; Stine Julie Tingskov; Mia Gebauer Madsen; Lene N Nejsum; Helle Praetorius; Rikke Nørregaard
Journal:  Acta Physiol (Oxf)       Date:  2022-01-30       Impact factor: 7.523

4.  Prostaglandin E2 stimulates the epithelial sodium channel (ENaC) in cultured mouse cortical collecting duct cells in an autocrine manner.

Authors:  Morag K Mansley; Christian Niklas; Regina Nacken; Kathrin Mandery; Hartmut Glaeser; Martin F Fromm; Christoph Korbmacher; Marko Bertog
Journal:  J Gen Physiol       Date:  2020-08-03       Impact factor: 4.086

5.  A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE2 on AQP2 Expression.

Authors:  Peter M T Deen; Michelle Boone; Horst Schweer; Emma T B Olesen; Claudia Carmone; Jack F M Wetzels; Robert A Fenton; Marleen L A Kortenoeven
Journal:  Front Physiol       Date:  2022-01-21       Impact factor: 4.566

6.  The association of urinary prostaglandins with uric acid in hyperuricemia patients.

Authors:  Huagang Lin; Ying Xu; Yuqi Zheng; Deping Wu; Zhibin Ye; Jing Xiao
Journal:  BMC Nephrol       Date:  2022-09-03       Impact factor: 2.585

Review 7.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

8.  Differential roles of VPS and RAAS in water homeostasis and a risk for kidney dysfunction in rats undergoing rapid fasting/dehydration with regular exercise.

Authors:  KazuyA Hasegawa; Yuya Yamaguchi; Masashi Tanaka
Journal:  Physiol Rep       Date:  2021-01

9.  Prostaglandin E2 receptors as therapeutic targets in renal fibrosis.

Authors:  Henricus A M Mutsaers; Rikke Nørregaard
Journal:  Kidney Res Clin Pract       Date:  2022-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.